Breaking Down Tangrenshen Group Co., Ltd Financial Health: Key Insights for Investors

CN | Consumer Defensive | Food Distribution | SHZ

Tangrenshen Group Co., Ltd (002567.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Curious whether Tangrenshen Group Co., Ltd. (002567.SZ) is a turnaround candidate or a cautionary tale? In Q1 2025 the company reported revenue of CNY 5.97 billion (up 22.40% year-on-year) against a trailing twelve months (TTM) revenue of CNY 25.44 billion (up 0.51% YoY) after a full-year 2024 revenue decline to CNY 24.34 billion (-9.67%); yet profitability paints a mixed picture with TTM net income of CNY -263.16 million (EPS -0.18) and a Q1 2025 net loss of CNY -77.05 million (loss per share -0.0538), while operating cash flow of CNY 1.21 billion and free cash flow of CNY 887.96 million coexist with total debt of CNY 6.12 billion, total equity of CNY 6.17 billion (debt-to-equity 99.1%) and cash balances reported as CNY 2.2-2.4 billion; valuation and market signals show a market cap near CNY 6.9 billion with share price CNY 4.880 (July 11, 2025), a trailing P/E of 14.39, P/S of 0.27 and EV/EBITDA of 7.13, while liquidity and solvency metrics deliver contrasts - current ratio 1.11, quick ratio 0.46, an Altman Z-Score of 1.92 and a Piotroski F-Score of 8 - and operational levers such as revenue per employee of CNY 2.15 million (11,805 employees), plans to boost sow utilization to over 90% and raise own-piglet supply above 80% all sit alongside industry risks and an interest coverage ratio of 0.8; read on to unpack these figures, what they mean for investors and which metrics deserve the closest scrutiny.

Tangrenshen Group Co., Ltd (002567.SZ) - Revenue Analysis

Tangrenshen reported strong top-line momentum in Q1 2025 with revenue of CNY 5.97 billion, up 22.40% year-over-year. On a trailing twelve months (TTM) basis revenue is CNY 25.44 billion, showing modest y/y growth of 0.51% despite a full-year revenue decline in 2024.
  • Q1 2025 revenue: CNY 5.97 billion (+22.40% vs Q1 2024)
  • TTM revenue: CNY 25.44 billion (+0.51% vs prior TTM)
  • FY 2024 revenue: CNY 24.34 billion (-9.67% vs FY 2023)
  • Revenue per employee: ~CNY 2.15 million (11,805 employees)
  • Market capitalization: CNY 6.91 billion (share price CNY 4.880 as of 2025-07-11)
  • Price-to-sales (P/S) ratio: 0.27
Metric Value Change
Q1 2025 Revenue CNY 5.97 billion +22.40% y/y
TTM Revenue CNY 25.44 billion +0.51% y/y
FY 2024 Revenue CNY 24.34 billion -9.67% y/y
Employees 11,805 -
Revenue per Employee CNY 2.15 million -
Market Capitalization CNY 6.91 billion As of 2025-07-11
Share Price CNY 4.880 As of 2025-07-11
Price-to-Sales (P/S) 0.27 -
Key implications for revenue interpretation:
  • Q1 2025 jump suggests improved seasonal or operational performance vs 2024 doldrums.
  • TTM flatness (+0.51%) indicates recent gains are only beginning to offset the FY2024 decline (-9.67%).
  • Low P/S (0.27) and market cap of CNY 6.91 billion imply market valuation is conservative relative to sales scale.
  • Revenue per employee (~CNY 2.15M) provides a productivity benchmark for peer comparisons.
Further company context and background available here: Tangrenshen Group Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Tangrenshen Group Co., Ltd (002567.SZ) - Profitability Metrics

Tangrenshen Group's recent profitability profile shows mixed signals: modest operating performance, thin gross margins, and an overall net loss on a trailing twelve-month basis. Key headline figures are presented below and detailed in the accompanying table.

  • Trailing twelve months (TTM) net income: CNY -263.16 million; TTM EPS: CNY -0.18.
  • Operating margin: 2.94%; Profit margin: 1.87%; EBIT margin: 2.94% with EBIT of CNY 747.31 million.
  • Gross margin: 8.69%, indicating limited markup above cost of goods sold.
  • Return on equity (ROE): 6.55%, a moderate return relative to shareholders' equity.
  • Q1 2025 reported net loss: CNY 77.05 million; loss per share: CNY -0.0538.
Metric Value Notes / Period
Net income (TTM) CNY -263.16 million Trailing twelve months
Earnings per share (EPS, TTM) CNY -0.18 Trailing twelve months
Operating margin 2.94% Operating profit / Revenue
Profit margin 1.87% Net profit / Revenue
EBIT CNY 747.31 million Earnings before interest and taxes
EBIT margin 2.94% EBIT / Revenue
Gross margin 8.69% Revenue minus COGS as % of Revenue
Return on equity (ROE) 6.55% Net income / Shareholders' equity
Q1 2025 net income CNY -77.05 million Quarterly result (Q1 2025)
Q1 2025 loss per share CNY -0.0538 Q1 2025

For related corporate context and strategic orientation, see: Mission Statement, Vision, & Core Values (2026) of Tangrenshen Group Co., Ltd.

Tangrenshen Group Co., Ltd (002567.SZ) - Debt vs. Equity Structure

Tangrenshen Group's capital structure shows near parity between debt and equity, with balance-sheet metrics that investors should weigh carefully against operating performance and liquidity.
  • Debt-to-equity ratio: 99.1% (nearly 1:1).
  • Total debt: CNY 6.12 billion.
  • Total equity: CNY 6.17 billion.
  • Interest coverage ratio: 0.8 - operating income covers less than one time the interest expense.
  • Total assets: CNY 17.9 billion; total liabilities: CNY 11.7 billion.
  • Cash & short-term investments: CNY 2.2 billion.
  • Net debt: CNY -4.56 billion (net cash position).
Metric Amount (CNY) Comment
Total Assets 17,900,000,000 Asset base supporting operations
Total Liabilities 11,700,000,000 Includes the CNY 6.12B total debt
Total Debt 6,120,000,000 Interest-bearing obligations
Total Equity 6,170,000,000 Shareholders' equity
Debt-to-Equity Ratio 99.1% Near equal financing by debt and equity
Interest Coverage Ratio 0.8 Operating income < interest expense
Cash & Short-term Investments 2,200,000,000 Available liquidity
Net Debt (Net Cash) -4,560,000,000 Cash exceeds interest-bearing debt

Key implications for investors:

  • Balance-sheet strength: substantial asset base (CNY 17.9B) with equity roughly equal to debt supports solvency but requires monitoring.
  • Liquidity vs. coverage: CNY 2.2B in cash/short-term investments contributes to a net cash position (net debt -CNY 4.56B), yet the low interest coverage (0.8) signals operating earnings may be insufficient to comfortably service interest if costs rise or revenue falls.
  • Leverage dynamics: a 99.1% debt-to-equity ratio implies vulnerability to earnings shocks despite net cash - because interest obligations relative to operating profit are strained.

For broader corporate context and background on the company's strategy and ownership, see: Tangrenshen Group Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Tangrenshen Group Co., Ltd (002567.SZ) - Liquidity and Solvency

Tangrenshen Group's near-term liquidity picture shows adequate current assets relative to current liabilities but limited immediate liquidity when inventory is excluded. Solvency indicators and cash position reveal elevated leverage and a net debt posture that warrants scrutiny despite strong operating cash generation and solid accounting-score metrics.

  • Current ratio: 1.11 - sufficient short-term assets to cover short-term liabilities.
  • Quick ratio: 0.46 - indicates potential difficulty meeting short-term obligations without liquidating inventory.
  • Altman Z‑Score: 1.92 - below 3, implying a higher risk of financial distress.
  • Piotroski F‑Score: 8 - strong score reflecting profitability, leverage/solvency improvements, and operational efficiency.
Metric Value Unit / Note
Current Ratio 1.11 Times
Quick Ratio 0.46 Times
Altman Z‑Score 1.92 Score ( distress risk <3 )
Piotroski F‑Score 8 Score (0-9; higher is better)
Cash & Cash Equivalents 2.40 CNY billion
Total Debt 6.95 CNY billion
Net Cash (Net Debt) -4.56 CNY billion (net debt)
Operating Cash Flow 1.21 CNY billion
Capital Expenditures -0.31714 CNY billion
Free Cash Flow 0.88796 CNY billion

Key contextual points for investors:

  • Net debt of CNY -4.56 billion (CNY 2.40b cash vs. CNY 6.95b debt) increases financial leverage despite comfortable operating cash flow of CNY 1.21 billion.
  • Free cash flow of CNY 887.96 million after CNY 317.14 million of capex provides cash to service debt, invest, or return capital, but the company remains net debtor.
  • Low quick ratio (0.46) signals reliance on inventory turnover or asset sales if immediate liquidity is required; monitor inventory levels and receivable collection days.
  • Contrasting signals: a robust Piotroski F‑Score (8) suggests improving fundamentals, while the Altman Z‑Score (1.92) flags elevated bankruptcy risk under stress scenarios.

For background on the company's strategy, ownership and business model, see: Tangrenshen Group Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

Tangrenshen Group Co., Ltd (002567.SZ) - Valuation Analysis

Tangrenshen Group's current market multiples and capital structure suggest a modestly valued mid-cap food producer with mixed signals between earnings-based and sales-based valuations. The following metrics summarize market-implied expectations and relative risk:
  • Trailing P/E: 14.39 - investors are paying CNY 14.39 for each CNY 1 of trailing earnings.
  • Forward P/E: 22.23 - the market prices in expected earnings growth or near-term earnings compression.
  • P/B: 1.06 - shares trade only slightly above book value, indicating limited tangible value premium.
  • EV/EBITDA: 7.13 - a moderate multiple that can indicate reasonable operating earnings valuation versus peers.
  • EV/Sales: 0.47 - low valuation relative to revenue, pointing to either thin margins or a conservative revenue-based valuation.
  • Market cap: CNY 6.82 billion; Enterprise value: CNY 12.04 billion - the gap reflects net debt and minority interests.
  • 52-week change: -11.17%; Beta: 0.83 - price slightly down over the year with lower volatility than the market.
Metric Value Interpretation
Trailing P/E 14.39 Attractive vs. high-growth peers; implies reasonable historical earnings valuation
Forward P/E 22.23 Market expects earnings growth or foresees near-term margin pressure
P/B 1.06 Shares near book value - limited intangible premium
EV/EBITDA 7.13 Moderate enterprise valuation relative to operating cash profit
EV/Sales 0.47 Low revenue multiple - potential undervaluation or low margin business
Market Capitalization CNY 6.82 billion Size: small-to-mid cap
Enterprise Value CNY 12.04 billion Includes net debt exposure
52-Week Price Change -11.17% Moderate negative performance over 1 year
Beta (3y) 0.83 Lower volatility than broad market
  • Implication for valuation comparison: EV/Sales of 0.47 and P/B near 1 suggest revenue and asset bases are valued conservatively, while the forward P/E of 22.23 shows the market expects improvement in earnings or assigns a premium to future prospects.
  • Capital structure impact: Enterprise value (CNY 12.04bn) materially exceeds market cap (CNY 6.82bn), implying net debt or lease liabilities that investors must account for when assessing takeover or free-cash-flow-based valuations.
  • Risk/volatility consideration: Beta 0.83 implies downside is likely less correlated with market swings, but a negative 52-week return (-11.17%) signals recent investor caution.
For deeper shareholder composition, trading activity and historical financials, see: Exploring Tangrenshen Group Co., Ltd Investor Profile: Who's Buying and Why?

Tangrenshen Group Co., Ltd (002567.SZ) - Risk Factors

Tangrenshen Group operates in China's highly competitive and fragmented pork industry, exposing the company to operational, market, and financial risks that investors should weigh carefully. Key quantitative indicators highlight areas of strength and vulnerability.

  • Industry competition and fragmentation: many regional players and low barriers to entry increase price competition and margin pressure.
  • Pork-price volatility: market prices for hogs can swing sharply due to seasonal demand, policy changes, export/import dynamics, and consumer preferences.
  • Disease and biosecurity risk: outbreaks (e.g., ASF-like events) can force herd culls, disrupt supply chains, and produce abrupt revenue declines.
  • Feed-cost exposure: feed grain price swings materially affect production costs and gross margins.
Metric Value / Note
Debt-to-Equity Ratio 99.1%
Altman Z-Score 1.92 (elevated financial distress risk)
Interest Coverage Ratio 0.8 (operating income covers <1x interest expense)
Piotroski F-Score 8 (strong operational/financial signals)
Industry Pork production - high cyclicality and fragmentation
  • Leverage concerns: a near 1:1 debt-to-equity ratio (99.1%) increases solvency sensitivity to revenue shocks and margin compression; refinancing or higher interest rates would raise cash-flow strain.
  • Interest-service pressure: with an interest coverage ratio of 0.8, Tangrenshen's operating income is currently insufficient to cover interest expense comfortably, raising default or covenant breach risk if operating performance weakens.
  • Distress signal: an Altman Z-Score of 1.92 sits below typical safe thresholds (generally >2.6), indicating elevated probability of financial distress under adverse conditions.
  • Offsetting strengths: a Piotroski F-Score of 8 suggests recent improvements in profitability, liquidity, and operational efficiency, but it does not eliminate market or leverage risks.
  • External shocks: biological outbreaks, policy shifts (e.g., sanitary regulation, environmental limits), or sudden feed-price spikes can rapidly reverse short-term gains and amplify leverage-related vulnerabilities.
  • Monitoring priorities for investors:
    • Quarterly operating cash flow and EBITDA trends relative to interest expense.
    • Changes in herd size, production capacity utilization, and biosecurity measures.
    • Short-term vs. long-term debt maturities and refinancing needs.
    • Exposure to feed-price movements and hedging or procurement strategies.

For company context and stated strategic direction, see: Mission Statement, Vision, & Core Values (2026) of Tangrenshen Group Co., Ltd.

Tangrenshen Group Co., Ltd (002567.SZ) - Growth Opportunities

Tangrenshen Group's stated operational and strategic targets point to several concrete growth levers that can materially improve margin resilience and scale. Key numerical targets already guiding operations:
  • Target sow production capacity utilization rate: >90% by year-end.
  • Target share of own-supplied piglets: >80% of total replacement/supply.
Operational levers and expected impacts:
  • Vertical integration: increasing internal piglet supply to >80% lowers external purchase volatility and can reduce per-head cost of piglet procurement by an estimated 20-35% versus market purchases.
  • Capacity utilization: moving utilization from typical mid-cycle levels (e.g., 70-80%) to >90% improves fixed-cost absorption - modeled uplift to operating margin of 150-400 basis points depending on feed cost environment.
  • Cost-reduction partnerships: targeting collaboration with top-tier industry players to benchmark and implement best-practice cost measures (procurement scale, shared logistics, joint feed R&D).
  • Low-cost farming focus: emphasis on barn efficiency, standardized low-cost units and regional concentration to reduce transport and mortality costs.
Technical and animal-health initiatives
  • Optimized feed formulations: formulation changes and bulk sourcing expected to reduce feed conversion ratio (FCR) by ~0.05-0.15 points, equating to feed cost savings of roughly RMB 50-150 per finished pig (depending on feed price cycles).
  • Reproductive performance improvements: measures to increase litters per sow per year and reduce piglet mortality aimed at lifting piglets weaned per sow/year by an estimated 0.3-0.8 piglets, directly boosting output without proportional fixed-cost increases.
  • Biosecurity and health programs: investments targeted at lowering mortality and medication costs, potentially cutting veterinary expenses by 10-25% in optimized farms.
Investment priorities and expected returns
Investment Area Planned Scale/Amount Primary Benefit Estimated Payback
Breeding facilities (sow units & genetic programs) Incremental capacity to support >80% own piglet supply (capex range RMB 200-500m illustrative) Higher self-sufficiency, lower piglet procurement cost 3-6 years
Meat processing & cold chain Processing lines + cold storage (RMB 100-300m illustrative) Upgraded gross margins, market access, price realization 2-5 years
Feed optimization & procurement R&D + long-term supply contracts (RMB 30-80m) Lower FCR, stable input costs 1-3 years
Farm modernization (automation & biosecurity) Regional retrofits across core farms (RMB 150-350m) Lower labor, mortality, and overhead per head 2-4 years
Quantitative scenario illustration (indicative)
Metric Base Post-Execution Estimate Delta
Sow utilization 78% >90% +12 ppt
Own piglet supply ~55% >80% +25 ppt
Feed conversion ratio (FCR) ~2.55 ~2.45 -0.10
Operating margin ~6-8% ~8.5-12% +1.5-4 ppt
Market and execution considerations
  • Execution risk: hitting >90% utilization requires synchronized breeding, biosecurity, and logistics; short-term capital intensity may pressure free cash flow.
  • Commodity exposure: feed and live hog price volatility remain primary external drivers; hedging and long-term contracts can mitigate but not eliminate exposure.
  • Scale economies: expanding own-piglet ratio and processing capacity should improve price realization and reduce per-unit cost as volumes increase.
Further context and corporate background can be reviewed here: Tangrenshen Group Co., Ltd: History, Ownership, Mission, How It Works & Makes Money

DCF model

Tangrenshen Group Co., Ltd (002567.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.